FLUBIT.COM
70 Million household items can now be bought worldwide, as acceptance of over forty cryptocurrencies becomes the flagship payment option on MonetaryUnit’s ($MUE) relaunch of the largest UK independent marketplace.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181108005043/en/
As cryptocurrency grew to see $15BN in daily trading volume throughout October, MonetaryUnit’s summer acquisition (flubit.com) has launched the world’s largest integrated shopping marketplace for cryptocurrency. Importantly for the wider crypto industry, this provides fresh validation for those seeking to make cryptocurrency an everyday payment asset.
Byron Barnard from the MonetaryUnit Blockchain project, spoke today about the key challenges in a push towards crypto adoption in everyday life. “Our focus is to create environments that are accessible to all and free from the stigma that the blockchain/crypto space is only for techies. Online shoppers expect the ease of checkout that card-payments currently gives them; prior to today that just hasn’t been possible at scale with cryptocurrency. On Flubit.com you can now simply choose any item from multiple sellers, select your preferred coin, and pay within a few clicks. Millions of everyday household items can be bought with crypto and zero fuss”.
Flubit.com (a marketplace similar to Amazon’s offering), connects thousands of suppliers together, allowing users to purchase different items directly from multiple sellers in one basket. A setback to previous use-cases of cryptocurrency has been a slow adoption-rate from traditional businesses, but as Steph Fiala, Chief Operating Officer of Flubit.com explains, that is no longer a pain-point for sellers. “Sellers won’t know if they’ve received an order paid with a crypto or fiat currency. Where required and prior to an order being sent through to a seller, our technology automatically converts crypto payments into their native-currency. Sellers can now access a $15bn/day industry risk-free, an advantage they cannot get via other marketplaces”.
Flubit.com, the 8 year-old eCommerce company (and winners of the prestigious Web Summit competition) has already seen a surge in demand from communities wishing to have their coins added as payment options. Flubit.com’s CEO, Bertie Stephens, adds that “Being part of the Flubit.com shopping ecosystem creates demand for a coin, increases volume of trading, and consequently helps grow a coin’s value and future relevance. Any community can apply, and we consider applications of those coins that we believe meet the same ethos as MonetaryUnit’s own blockchain and crypto technologies”.
Since announcing the acquisition of the Flubit.com marketplace, (who had over 3 million shoppers through its doors last year), MonetaryUnit’s $MUE coin has shot up 37% in value. The coins available at the launch of Flubit.com crypto offering are:
BitCoin, BitCoin Cash, Dash, DogeCoin, Ethereum, Ethereum Classic, Komodo, LiteCoin, Ripple XRP, XMR Monero, Beancash, BlackCoin, Bitcoin gold, CloakCoin, Crown, Decred, DigiByte, Game credits, Groestlcoin, Lisk, MaidSafeCoin, NavCoin, Neo, Namecoin, Nxt, Peercoin, Pura, Qtum, SmartCash, Stratis, Syscoin, TokenPay, Tron, Ubiq, Vertcoin, Waves, NEM, Verge, ZCoin, Zcash and Horizen
Further Information:
View source version on businesswire.com: https://www.businesswire.com/news/home/20181108005043/en/
Contact:
Flubit.com Ashley Hill ashley.hill@flubit.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release
Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release
Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release
New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom